Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

Heart Rhythm: AI predicts AFib | How the iPhone 12 can put patients at risk | FDA announces an urgent recall

News You Need to Know Today
Heart Rhythm: AI predicts AFib | How the iPhone 12 can put patients at risk | FDA announces an urgent recall
Tuesday, February 23, 2021
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Heart Rhythm

AI predicts new-onset AFib using 12-lead ECGs

The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI predicts new-onset AFib using 12-lead ECGs

Share on Twitter Share on Facebook Share on Linkedin
The team's deep neural network was trained on more than 1.6 million 12-lead ECGs. 
READ MORE >

Warning: iPhone 12 capable of deactivating implantable cardiac devices, putting patients at risk

"We were all stunned," one cardiologist said after discovering the problem.

READ MORE >
Smartphone
Share on Twitter Share on Facebook Share on Linkedin

Warning: iPhone 12 capable of deactivating implantable cardiac devices, putting patients at risk

Share on Twitter Share on Facebook Share on Linkedin
Smartphone
"We were all stunned," one cardiologist said after discovering the problem.
READ MORE >

Energy drinks may damage the heart, researchers warn—should the FDA get involved?

The authors assessed 17 popular energy drinks, sharing their analysis in Food and Chemical Toxicology. 

READ MORE >
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
Share on Twitter Share on Facebook Share on Linkedin

Energy drinks may damage the heart, researchers warn—should the FDA get involved?

Share on Twitter Share on Facebook Share on Linkedin
Sen. Chunk Schumer has asked the U.S. Food and Drunk Administration (FDA) to investigate the high amount of caffeine found in energy drinks sold by Prime, a beverage brand founded by YouTube personalities Logan Paul and KSI. According to Schumer, the “eye-popping 200 mg of caffeine” found in a single Prime energy drink is troubling, especially for a product marketed primarily to children.
The authors assessed 17 popular energy drinks, sharing their analysis in Food and Chemical Toxicology. 
READ MORE >

Ablation could be ‘a powerful new strategy’ for treating heart failure patients with atrial fibrillation

According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

Ablation could be ‘a powerful new strategy’ for treating heart failure patients with atrial fibrillation

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
According to a new study published in Circulation, ablation was associated with numerous benefits over standard drug therapy.
READ MORE >

AI filter helps heart-monitoring devices limit false-positive AFib findings

The AI filter used in the study included two separate convolutional neural networks trained on more than one million ECGs.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

AI filter helps heart-monitoring devices limit false-positive AFib findings

Share on Twitter Share on Facebook Share on Linkedin
The AI filter used in the study included two separate convolutional neural networks trained on more than one million ECGs.
READ MORE >

High blood pressure associated with greater risk of atrial fibrillation

The new analysis, published in the European Journal of Preventive Cardiology, confirmed that atrial fibrillation can be prevented. 

READ MORE >
UW Medicine Regional Heart Center
Share on Twitter Share on Facebook Share on Linkedin

High blood pressure associated with greater risk of atrial fibrillation

Share on Twitter Share on Facebook Share on Linkedin
UW Medicine Regional Heart Center
The new analysis, published in the European Journal of Preventive Cardiology, confirmed that atrial fibrillation can be prevented. 
READ MORE >

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  

READ MORE >
Product Recall
Share on Twitter Share on Facebook Share on Linkedin

FDA announces recall of Boston Scientific’s EMBLEM S-ICD Subcutaneous Electrode—26 injuries, 1 death reported

Share on Twitter Share on Facebook Share on Linkedin
Product Recall
The FDA categorized this as a Class I recall, which means it is an especially serious issue that can result in injury or death.  
READ MORE >

‘A very lethal combination’: COVID-19 patients much more likely to die from sudden cardiac arrest

Sudden cardiac arrest, both in and outside of the hospital, is much more fatal for patients who already have COVID-19. 

READ MORE >
COVID
Share on Twitter Share on Facebook Share on Linkedin

‘A very lethal combination’: COVID-19 patients much more likely to die from sudden cardiac arrest

Share on Twitter Share on Facebook Share on Linkedin
COVID
Sudden cardiac arrest, both in and outside of the hospital, is much more fatal for patients who already have COVID-19. 
READ MORE >

Medtronic’s new AFib ablation system gains FDA approval

The system sends real-time feedback to healthcare providers during the treatment process. 

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new AFib ablation system gains FDA approval

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The system sends real-time feedback to healthcare providers during the treatment process. 
READ MORE >

Confirmed: AFib patients with COVID-19 face a greater risk of death

The meta-analysis included data from 23 different studies. 

READ MORE >
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
Share on Twitter Share on Facebook Share on Linkedin

Confirmed: AFib patients with COVID-19 face a greater risk of death

Share on Twitter Share on Facebook Share on Linkedin
Even patients who were never hospitalized for COVID-19 face a heightened risk of cardiovascular issues. #longcovid
The meta-analysis included data from 23 different studies. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: CCTA on ACC expo floor gives cardiologist wake-up call | Reaction to CMS TAVR changes | Recalls and new AI
CCTA scan provides a wake-up call | Resistance training & heart attack risk in women | New ultrasound tech | AFib & grout
FDA clears first surgical valve of its kind | Family files $17M lawsuit | BATMAN to the rescue | Major trends at SCCT 2026
Early reactions to proposed TAVR changes | Cardiology still an AI leader | More than 11K bottles of blood pressure drug recalled
TV star's family awarded $13M in malpractice case | Helping patients with ‘broken hearts’ | Cardiac amyloidosis in the spotlight
CMS proposes major TAVR changes | The real impact of RVU cuts in electrophysiology | Girl’s heart valve implanted upside down
News Alert: CMS proposes major TAVR changes

Pagination

    • Current page 1
    • Page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme